SHANGHAI, April 11, 2026 /PRNewswire/ — At the 93rd China International Medical Equipment Exhibition (CMEF), Sinocare showcased its latest advancements under the theme “Leading Digital Healthcare for Global Health”. By bringing together cutting-edge technologies, integrated solutions and strategic partnerships, the company has demonstrated its ambition to redefine chronic disease management globally.
Building a full-stack digital health ecosystem
Sinocare has unveiled a comprehensive digital ecosystem spanning wearables, home monitoring, primary care and clinical environments.
At the forefront is its continuous glucose monitoring (CGM) portfolio, featuring proprietary third-generation biosensor technology. These devices enable up to 15 days of real-time monitoring, powered by AI-driven analytics for predictive alerts, trend forecasts and personalized interventions. As China’s first CE-MDR certified CGM brand, Sinocare continues to expand in Europe, Southeast Asia and the Middle East.
In addition, a “Personal Palm Lab” portfolio covering glucose, blood pressure, uric acid, lipids and ketones. Through AI-driven data integration and automated risk alerts, these solutions improve continuous, intelligent, and visualized home health management.
For primary care and clinical settings, Sinocare has introduced integrated solutions including non-invasive diabetes risk screening (AGEscan), portable multi-function analyzers and HbA1c systems. These platforms enable standardized testing in community clinics, pharmacies and health centers, improving accessibility and supporting healthcare delivery on multiple levels.
Strategic partnerships for ecosystem expansion
During CMEF, Sinocare announced two major partnerships to strengthen its ecosystem approach:
- Collaboration with JD Health to build a closed-loop model integrating testing, repurchase and long-term management.
- Partnering with Meituan Healthcare to expand access through omnichannel distribution and public health initiatives.
Together, these collaborations enhance Sinocare’s product, data, service and channel capabilities.
From Chinese leadership to global impact
Through expert presentations, Sinocare shared its knowledge on managing the full cycle of chronic diseases, from hospital to home, from monitoring to intervention. Its CGM-based data systems help move diabetes care from experience-based to data-driven precision.
The company also presented its MIT intensive intervention model, integrating medical nutrition, intelligent monitoring and behavioral support to enable structured pathways to disease reversal.
Today, Sinocare ranks among the world’s four largest blood glucose meter companies, serving more than 25 million users in 187 countries. In the future, it will continue to leverage AI and biosensing technologies to usher in a new era of intelligent, precise and lifecycle-based management of chronic diseases worldwide.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/sinocare-showcases-digital-innovation-at-the-93rd-cmef-advancing-global-chronic-disease-management-302739742.html
SOURCE Sinocare
